Interpat

Ideas
Protected for all

China IP Study now available

Innovation Seminar, Brazil

28-29 November 2023

The biopharma Intellectual Property think tank

We’re Interpat: The biopharmaceutical think tank that supports policy makers and implementors to ensure that the ideas of the future can flourish. We do this by advocating for robust tried and tested Intellectual Property frameworks that deliver certainty and security.

Membership

We actively promote the transformational benefits of IP and its power to drive original thinking in the Life Sciences. We do this with our members, governments, intergovernmental bodies, NGOs and wider society and we work tirelessly to advocate for healthcare innovation around the world

Sharing expertise

Cross-industry support

Sustainable innovation

Supporting leaders

Reviewing best practice

Ideas incubator

Unprecedented: The Rapid Innovation Response to COVID-19 and the Role of IP

The COVID-19 pandemic presented humanity with unprecedented challenges. Researchers and biopharmaceutical companies responded by developing and delivering COVID-19 vaccines and treatments in record time. The innovation response to COVID-19 has been a singular achievement, but we will not be done until every person who needs a vaccine can get one.

South Korea IP Study

INTERPAT asked Charles River Associates (CRA) to identify and quantify the economic benefits from strengthening the environment for innovation in South Korea.

Our members

Our members are some of the world’s leading biopharmaceutical companies, committed to finding innovative ways to design and deliver products that meet global healthcare challenges.

Find out more

Use our quick contact form to get in touch .